Skip to main content

Want a detailed portfolio tracker?

Performance analysis of AbCellera Biologics (ABCL)

Annual Return

Over the past 3 years, ABCL has had an average annual return of -8.73%, underperforming the benchmark SPY, which returned +19.63% annual.

Over the past 5 years, ABCL has had an average annual return of -17.93%, underperforming the benchmark SPY, which returned +12.73% annual.

Since Dec 11, 2020, ABCL has had an average annual return of -33.50%, underperforming the benchmark SPY, which returned +15.18% annual.

2026202520242023202220212020
+74.53%+16.90%-48.71%-43.66%-29.16%-64.46%-31.68%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026+5.85%-0.33%-3.26%+18.89%+48.65%+27.19%-23.93%+74.53%
2025+8.25%-18.40%-13.67%+16.89%-22.57%+69.68%+30.41%-6.46%+20.28%+10.30%-32.80%-8.21%+16.90%
2024-10.42%-1.27%-10.27%-16.51%+3.74%-24.47%+9.94%-21.34%+1.38%+4.99%+10.37%-2.74%-48.71%
2023+3.95%-20.25%-10.24%-10.08%+2.78%-7.27%+19.60%-29.50%-15.57%-10.63%+14.61%+21.13%-43.66%
2022-37.15%-3.08%+11.90%-21.33%-0.61%+39.72%-5.70%+6.33%-7.39%+19.59%+8.81%-21.28%-29.16%
2021+31.28%-28.62%-9.93%-21.52%+0.66%-18.00%-31.03%+10.60%+19.41%-21.60%-4.76%-4.41%-64.46%
2020-31.68%-31.68%

Drawdown analysis of AbCellera Biologics (ABCL)

The maximum drawdown for the ABCL was -96.72%, occurring on Apr 8, 2025. This drawdown has not yet recovered.

The current ABCL drawdown is -89.86%.

Since Dec 11, 2020 ABCL has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 1 time
  • 10% or more: 1 time
DepthStartTo BottomBottomTo RecoverEndTotal
-96.72%Dec 11, 20201084Apr 8, 2025OngoingOngoingOngoing